- Home
- CPS vs DMAC Comparison
CPS vs DMAC Comparison
Compare CPS & DMAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPS
- DMAC
- Stock Information
- Founded
- CPS 1960
- DMAC 2000
- Country
- CPS United States
- DMAC United States
- Employees
- CPS N/A
- DMAC N/A
- Industry
- CPS Auto Parts:O.E.M.
- DMAC Biotechnology: Pharmaceutical Preparations
- Sector
- CPS Consumer Discretionary
- DMAC Health Care
- Exchange
- CPS Nasdaq
- DMAC Nasdaq
- Market Cap
- CPS 232.1M
- DMAC 190.2M
- IPO Year
- CPS N/A
- DMAC N/A
- Fundamental
- Price
- CPS $13.55
- DMAC $4.29
- Analyst Decision
- CPS
- DMAC Strong Buy
- Analyst Count
- CPS 0
- DMAC 3
- Target Price
- CPS N/A
- DMAC $7.00
- AVG Volume (30 Days)
- CPS 126.8K
- DMAC 59.2K
- Earning Date
- CPS 10-31-2024
- DMAC 11-11-2024
- Dividend Yield
- CPS N/A
- DMAC N/A
- EPS Growth
- CPS N/A
- DMAC N/A
- EPS
- CPS N/A
- DMAC N/A
- Revenue
- CPS $2,794,468,000.00
- DMAC N/A
- Revenue This Year
- CPS N/A
- DMAC N/A
- Revenue Next Year
- CPS $9.36
- DMAC N/A
- P/E Ratio
- CPS N/A
- DMAC N/A
- Revenue Growth
- CPS 3.01
- DMAC N/A
- 52 Week Low
- CPS $11.24
- DMAC $2.05
- 52 Week High
- CPS $20.82
- DMAC $4.95
- Technical
- Relative Strength Index (RSI)
- CPS 50.23
- DMAC 50.76
- Support Level
- CPS $12.94
- DMAC $4.18
- Resistance Level
- CPS $13.38
- DMAC $4.77
- Average True Range (ATR)
- CPS 0.65
- DMAC 0.19
- MACD
- CPS 0.01
- DMAC -0.02
- Stochastic Oscillator
- CPS 47.80
- DMAC 27.27
About CPS Cooper-Standard Holdings Inc.
Cooper-Standard Holdings Inc is a supplier of rubber and resin products for the automotive industry. The company produces rubber and plastic sealings, fuel and brake lines, fluid transfer hoses, and anti-vibration systems used by original equipment manufacturers and replacement markets for passenger vehicles and light trucks. The largest customers include Ford, GM, FCA, Peugeot Citroen, and Volkswagen. Cooper Standard generates the majority of its revenue with its sealing systems products such as Fortrex, dynamic and static seals, stainless steel trims, flush glass systems, and variable extrusions.
About DMAC DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.